U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07023445) titled 'Patterns of Inclisiran Use in the Real World: An Analysis of US Databases' on June 10.
Brief Summary: This was a retrospective observational cohort study of patients who initiated inclisiran, alirocumab, or evolocumab in a real-world setting in the United States. The study used data extracted from three databases: (1) open and closed claims from Komodo's Healthcare map and electronic medical records (EMRs) from outpatient clinics affiliated with (2) Healix and (3) Metro Infusion Centers.
The study period spanned from 01 January 2021 to the latest date of the available data for each database. Index date was defined as the date of th...